Edina Tolnay

481 total citations
16 papers, 388 citations indexed

About

Edina Tolnay is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Edina Tolnay has authored 16 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Edina Tolnay's work include Liver physiology and pathology (4 papers), Cancer Cells and Metastasis (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Edina Tolnay is often cited by papers focused on Liver physiology and pathology (4 papers), Cancer Cells and Metastasis (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Edina Tolnay collaborates with scholars based in Hungary, Germany and Austria. Edina Tolnay's co-authors include Thorsten Wiethege, C. Kuhnen, Klaus-Michael Müller, B. Voß, Klaus Müller, Tamás Forster, Thomas Muehlberger, András Nagy, Hans Ulrich Steinau and Zsuzsanna Cserép and has published in prestigious journals such as Lung Cancer, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and International Journal of Molecular Medicine.

In The Last Decade

Edina Tolnay

14 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edina Tolnay Hungary	11	238	114	106	65	44	16	388
Leo J. Ostruszka United States	7	191 0.8×	209 1.8×	130 1.2×	59 0.9×	23 0.5×	7	388
Yoshinori Imura Japan	14	289 1.2×	195 1.7×	120 1.1×	54 0.8×	10 0.2×	51	471
Jörn Rüssel Germany	8	123 0.5×	142 1.2×	49 0.5×	13 0.2×	28 0.6×	21	317
Laura July Canada	7	148 0.6×	339 3.0×	252 2.4×	26 0.4×	12 0.3×	9	623
Mihaela Druta United States	14	255 1.1×	252 2.2×	63 0.6×	65 1.0×	6 0.1×	43	437
Hiroshi Hirakawa Japan	9	87 0.4×	60 0.5×	107 1.0×	67 1.0×	6 0.1×	26	393
Camille Schiffler France	10	251 1.1×	152 1.3×	87 0.8×	46 0.7×	6 0.1×	24	385
Michael J. Pienta United States	7	172 0.7×	413 3.6×	155 1.5×	16 0.2×	38 0.9×	19	611
Mitsutoshi Shiba Japan	11	385 1.6×	212 1.9×	46 0.4×	15 0.2×	6 0.1×	56	551

Countries citing papers authored by Edina Tolnay

Since Specialization

Citations

This map shows the geographic impact of Edina Tolnay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edina Tolnay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edina Tolnay more than expected).

Fields of papers citing papers by Edina Tolnay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edina Tolnay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edina Tolnay. The network helps show where Edina Tolnay may publish in the future.

Co-authorship network of co-authors of Edina Tolnay

This figure shows the co-authorship network connecting the top 25 collaborators of Edina Tolnay. A scholar is included among the top collaborators of Edina Tolnay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edina Tolnay. Edina Tolnay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Tolnay, Edina, et al.. (2018). The efficacy and safety of bevacizumab in addition to platinum‑based chemotherapy for the first‑line treatment of patients with advanced nonsquamous non‑small‑cell lung cancer: Final results of AVALANCHE, an observational cohort study. Oncology Letters. 17(2). 1750–1760. 2 indexed citations

Sárosi, Veronika, György Losonczy, Edina Tolnay, et al.. (2014). Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE). Lung Cancer. 86(1). 54–58. 3 indexed citations

Ostoros, Gyula, Veronika Sárosi, György Losonczy, Edina Tolnay, & László Molnár. (2009). 9175 The effectiveness of erlotinib (Tarceva®) treatment in KRAS negative lung adenocarcinomas – preliminary results of an observational cohort study. European Journal of Cancer Supplements. 7(2). 559–559.

Nagy, András, et al.. (2008). Early Diagnosis of Chemotherapy-induced Cardiomyopathy: a Prospective Tissue Doppler Imaging Study. Pathology & Oncology Research. 14(1). 69–77. 35 indexed citations

Tolnay, Edina, et al.. (2006). Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.. PubMed. 53(6). 511–7. 20 indexed citations

Naim, Ramin, et al.. (2004). Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors. International Journal of Molecular Medicine. 14(5). 787–91. 3 indexed citations

Kuhnen, C., et al.. (2003). Impact of c-Met expression on angiogenesis in soft tissue sarcomas: correlation to microvessel-density. Journal of Cancer Research and Clinical Oncology. 129(7). 415–422. 11 indexed citations

Tolnay, Edina, et al.. (2000). Co-Expression of Vascular Endothelial Growth Factor and Its Receptor <i>flt-1</i> in Malignant Pleural Mesothelioma. Respiration. 67(1). 36–40. 41 indexed citations

Kuhnen, C., Marcus Lehnhardt, Edina Tolnay, et al.. (2000). Patterns of expression and secretion of vascular endothelial growth factor in malignant soft-tissue tumours. Journal of Cancer Research and Clinical Oncology. 126(4). 219–225. 38 indexed citations

10.

Tolnay, Edina, et al.. (1999). Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 435(1). 8–12. 55 indexed citations

11.

Kuhnen, C., Edina Tolnay, Hans Ulrich Steinau, B. Voß, & Klaus-Michael Müller. (1998). Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 432(4). 337–342. 24 indexed citations

12.

Tolnay, Edina, C. Kuhnen, B. Voß, Thorsten Wiethege, & Klaus Müller. (1998). Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 432(1). 61–65. 41 indexed citations

13.

Tolnay, Edina, et al.. (1998). Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. Journal of Cancer Research and Clinical Oncology. 124(6). 291–296. 83 indexed citations

14.

Tolnay, Edina, et al.. (1997). Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 123(11-12). 652–658. 17 indexed citations

15.

Tolnay, Edina, et al.. (1997). Expression and localization of thrombomodulin in preneoplastic bronchial lesions and in lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 430(3). 209–212. 13 indexed citations

16.

Herszényi, László, et al.. (1992). [Experience with hydrogen (H2) breath test].. PubMed. 133(39). 2483–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact